USPTO 2015–2025 USPTO PatentsView US Corporation

HLT, Inc.

USPTO PatentsView assignee record - 31 granted patents across 8 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, HLT ranks #10,054 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 8 technology areas.

#10,054
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.7/100)
14.7
avg claims per patent
-85%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10054 · US Corporation #10,054 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 31 grants
  • UPPER-Q #10,054/49,997
  • PHOTO-FINISH Handi-Foil
  • CPC-NARROW A61F · 8 areas
  • INNOV-THIN 31.7/100
  • CLAIMS-RICH 14.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -85% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Handi-Foil Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How HLT’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around HLT

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows HLT's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for HLT?

Each dot is one of HLT’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). HLT’s own 14.7 claims/patent is ABOVE the 5.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

HLT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 30.93131.1 05101520 Granted patents (volume) Avg claims / patent Hayashibara Co., Ltd. - 31, 5.81HayashibaraHB Innovations, Inc. - 31, 14.68HB InnovationsHexacheck Inc. - 31, 5.58HexacheckHi-lex Controls, Inc. - 31, 15.26Hi-lex ControlsHospira, Inc. - 31, 16.16HospiraHuanic Corporation - 31, 7.23HuanicHuizhou Great Harvest Worldwide Industry Co., Ltd - 31, 1Huizhou Great Har…Handi-Foil Corp. - 31, 1.81Handi-foilHLT, Inc. - 31, 14.65HLT
HLT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where HLT's grants concentrate

HLT, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 96.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (7 grants) versus a trough of 1 in 2021. By volume, HLT sits between Hayashibara Co., Ltd. and Handi-Foil Corp..

HLT's three-year grant acceleration

HLT, Inc. shows 1 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at HLT's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows HLT holds 31 patents at rank #10,051, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near HLT

By rank, the assignees closest to #10,051 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in HLT's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for HLT, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), HLT ranks #216 of 3,082 assignees by patent count in that subclass.

HLT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182019202020212022 1
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
HLT, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 16.1%
2016 7 22.6%
2017 6 19.4%
2018 5 16.1%
2019 4 12.9%
2020 2 6.5%
2021 1 3.2%
2022 1 3.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

HLT, Inc.'s patent record in context - here's where to go next.

  • HLT, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 96.8% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #10,054 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare HLT, Inc. against Hayashibara Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.